1. Academic Validation
  2. Leveraging engineered mitochondria through intercellular communication network for accelerated transport and delivery

Leveraging engineered mitochondria through intercellular communication network for accelerated transport and delivery

  • Nat Commun. 2025 Dec 23. doi: 10.1038/s41467-025-67837-8.
Yiwei Peng # 1 Datong Gao # 1 Yiliang Yang 1 Yitian Du 1 Zhenzhen Yang 1 Jiajia Li 1 Meng Lin 1 Yanxia Zhou 1 Xinru Li 1 Xianrong Qi 2
Affiliations

Affiliations

  • 1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, School of Pharmaceutical Sciences, Peking University, Beijing, PR China.
  • 2 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, School of Pharmaceutical Sciences, Peking University, Beijing, PR China. [email protected].
  • # Contributed equally.
Abstract

Inspired by the non-transmembrane transfer of mitochondria in cell-to-cell communications, herein, we report an original exploration to accelerate mitochondrial intercellular transport, and its application to exogenous cargo delivery. We discover that deliberate PINK1-targeted Mitophagy downregulation elevates mitochondrial transit capacity via multifaceted drivers-morphological adaptation, metabolic reprogramming, and respiratory enhancement. Capitalizing on this, we engineer high-speed mitochondrial vehicles for Photosensitizer hitchhiking, with spatiotemporal tracking elucidating its dynamic intercellular transit and physiological impacts. Through mitochondria's communication network-tunneling nanotubes (TNTs), the mitochondria-photosensitizer cotransporter achieves reinforced intercellular delivery, thereby inducing deep tumor penetration and enhanced photodynamic killing. Our work establishes a transformative mitochondria-hitchhiking platform for overcoming biological barriers in drug delivery and provides mechanistic insights into manipulating intercellular organelle transport for therapeutic applications.

Figures
Products